5 Result(s)

Article

Correction: Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder

Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, ** Nakahara… in Neurology and Therapy (2024)

Article

Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder

Anti-aquaporin-4 antibody-positive (AQP4-Ab+) neuromyelitis optica spectrum disorder (NMOSD) is a complement-mediated autoimmune disease in which unpredictable and relapsing attacks on the central nervous syst...

Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, ** Nakahara… in Neurology and Therapy (2024)

Article

A Response to: Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”

Dean M. Wingerchuk, Ina Zhang, Adrian Kielhorn, Minying Royston… in Neurology and Therapy (2022)

Article

Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease defined by attacks on the central nervous system that cause irreversible damage. Recent approval of NMOSD therapies warrants investigatio...

Dean M. Wingerchuk, Ina Zhang, Adrian Kielhorn, Minying Royston… in Neurology and Therapy (2022)

Article

Autoimmune Encephalitis in the ICU: Analysis of Phenotypes, Serologic Findings, and Outcomes

To report the clinical and laboratory characteristics, clinical courses, and outcomes of Mayo Clinic, Rochester, MN, ICU-managed autoimmune encephalitis patients (January 1st 2003–December 31st 2012).

Manoj K. Mittal, Alejandro A. Rabinstein, Sara E. Hocker… in Neurocritical Care (2016)